
A different route to cellular reprogramming
Cells + animalsCell-state signatures; senescence-associated features; mouse frailty and survival.
Read the finding in its actual setting. Every brief identifies the model, endpoint, primary source, access level, and the next unanswered question.

The collection includes null results, observational evidence, cell and animal experiments, a human trial reanalysis, and a clearly separated early sponsor report. It is not a comprehensive or independently replicated body of evidence.

Cell-state signatures; senescence-associated features; mouse frailty and survival.

Acute liver injury, metabolic regulation, and regenerative response.

Early safety observations and exploratory visual-function measures.

Lipid-chain composition; worm lifespan; human genetic associations.

Epigenetic age measures and acquisition of neural stem-cell identity.

Regeneration and recovery after experimental acute liver injury.

Cardiolipin metabolism, mitochondrial function, and muscle phenotype.

Blood NAD metabolites; hearing and physical-performance outcomes.

Spatial vibrational signatures, transcriptomic states, and senescence-associated tissue patterns.

Cell morphology, transcriptional patterns, and treatment-response profiles.

Proliferation, identity markers, stress readouts, and preclinical repair.

Proteomic aging-clock estimates in previously collected clinical samples.

Leukocyte telomere measurements, telomerase activity, and gene expression.

Human abundance associations; mouse intestinal, inflammatory, and functional outcomes.

Stem-cell stress, function, lipid remodeling, and mouse immune balance.
One question. A source trail. A decision you can explain.
Find out what your existing data can actually support.
A defined experiment, a comparable lab scope and a usable handover.